TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624909. A total of 8 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,676,700 | +431.7% | 458,500 | +292.6% | 0.00% | +300.0% |
Q2 2023 | $879,504 | -52.1% | 116,800 | -43.7% | 0.00% | -50.0% |
Q1 2023 | $1,835,490 | -44.5% | 207,400 | -42.8% | 0.00% | -60.0% |
Q4 2022 | $3,308,736 | +0.4% | 362,800 | -11.2% | 0.01% | +25.0% |
Q3 2022 | $3,297,000 | +25.9% | 408,600 | +17.3% | 0.00% | 0.0% |
Q2 2022 | $2,618,000 | -24.8% | 348,200 | -6.0% | 0.00% | +33.3% |
Q1 2022 | $3,480,000 | -22.1% | 370,600 | -33.6% | 0.00% | -25.0% |
Q4 2021 | $4,469,000 | +34.1% | 557,900 | +65.7% | 0.00% | 0.0% |
Q2 2021 | $3,333,000 | -20.4% | 336,700 | -7.2% | 0.00% | -33.3% |
Q1 2021 | $4,186,000 | +9.6% | 362,700 | -8.4% | 0.01% | +20.0% |
Q4 2020 | $3,819,000 | +48.7% | 395,800 | +38.8% | 0.01% | +25.0% |
Q3 2020 | $2,569,000 | -19.8% | 285,100 | +9.8% | 0.00% | -42.9% |
Q2 2020 | $3,202,000 | -21.1% | 259,700 | -42.6% | 0.01% | -22.2% |
Q1 2020 | $4,060,000 | +12.7% | 452,100 | +23.0% | 0.01% | 0.0% |
Q4 2019 | $3,602,000 | +162.0% | 367,600 | +84.0% | 0.01% | +125.0% |
Q3 2019 | $1,375,000 | -35.2% | 199,800 | -13.1% | 0.00% | -42.9% |
Q2 2019 | $2,122,000 | +73.2% | 229,900 | +194.4% | 0.01% | +75.0% |
Q1 2019 | $1,225,000 | -63.8% | 78,100 | -64.4% | 0.00% | -60.0% |
Q4 2018 | $3,382,000 | – | 219,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WINTRUST INVESTMENTS LLC | 42,100 | $1,605,000 | 0.43% |
GROUP ONE TRADING, L.P. | 885,500 | $29,416,000 | 0.31% |
Teewinot Capital Advisers, L.L.C. | 1,800 | $362,000 | 0.18% |
Timber Hill LLC | 40,400 | $1,342,000 | 0.05% |
SIMPLEX TRADING, LLC | 4,620 | $691,000 | 0.03% |
JPMORGAN CHASE & CO | 175,000 | $5,814,000 | 0.00% |